4/A//SEC Filing
Arbutus Biopharma Corp 4/A
Accession 0001140361-16-046997
$ABUSCIK 0001447028operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:10 PM ET
Size
5.6 KB
Accession
0001140361-16-046997
Insider Transaction Report
Form 4/AAmended
Murray Mark J.
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (right to buy)
2015-07-09+100,000→ 100,000 totalExercise: $17.57Exp: 2025-03-30→ Common Shares (100,000 underlying)
Footnotes (1)
- [F1]The option vests as follows: 1/3 on 3/30/2016; 1/3/ on 3/30/2017; and 1/3 on 3/30/2018.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001447028
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:10 PM ET
- Size
- 5.6 KB